Tundra Space

Tundra Space

Clinical Research Directory

Browse clinical research sites, groups, and studies.

Back to Studies
NOT YET RECRUITING
NCT07877987
PHASE1

The Impact of Dose on the Impairing, Intoxicating, and Abuse-Related Effects of Psilocybin

Sponsor: Johns Hopkins University

View on ClinicalTrials.gov

Summary

This study will evaluate the subjective and behavioral effects of psilocybin relative to placebo and alcohol.

Key Details

Gender

All

Age Range

21 Years - Any

Study Type

INTERVENTIONAL

Enrollment

80

Start Date

2027-03-01

Completion Date

2030-06-30

Last Updated

2026-10-16

Healthy Volunteers

Yes

Interventions

DRUG

0mg Psilocybin Capsule + 0.00% BAC Alcoholic Drink

Participants will self-administer a capsule containing 0mg psilocybin and a drink that contains alcohol dosed to 0.00% BAC.

DRUG

1mg Psilocybin Capsule + 0.00% BAC Alcoholic Drink

Participants will self-administer a capsule containing 1mg psilocybin and a drink that contains alcohol dosed to 0.00% BAC.

DRUG

5mg Psilocybin Capsule + 0.00% BAC Alcoholic Drink

Participants will self-administer a capsule containing 5mg psilocybin and a drink that contains alcohol dosed to 0.00% BAC.

DRUG

15mg Psilocybin Capsule + 0.00% BAC Alcoholic Drink

Participants will self-administer a capsule containing 15mg psilocybin and a drink that contains alcohol dosed to 0.00% BAC.

DRUG

25mg Psilocybin Capsule + 0.00% BAC Alcoholic Drink

Participants will self-administer a capsule containing 25mg psilocybin and a drink that contains alcohol dosed to 0.00% BAC.

DRUG

0mg Psilocybin Capsule + 0.08% BAC Alcoholic Drink

Participants will self-administer a capsule containing 0mg psilocybin and a drink that contains alcohol dosed to 0.08% BAC.

Locations (1)

Johns Hopkins University

Baltimore, Maryland, United States